AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,020.00
-100.00 (-1.95%)
Jun 12, 2026, 3:30 PM KST

AptaBio Therapeutics Revenue

AptaBio Therapeutics had revenue of 957.41M KRW in the quarter ending March 31, 2026, with 150.17% growth. This brings the company's revenue in the last twelve months to 4.27B, up 37.54% year-over-year. In the year 2025, AptaBio Therapeutics had annual revenue of 3.70B with 10.02% growth.

Revenue (ttm)
4.27B
Revenue Growth
+37.54%
P/S Ratio
33.01
Revenue / Employee
n/a
Employees
n/a
Market Cap
141.03B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.70B336.93M10.02%
Dec 31, 20243.36B3.04B937.76%
Dec 31, 2023323.87M275.52M569.80%
Dec 31, 202248.35M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition